مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| ارزیابی کیفیت زندگی بیماران مبتلا به یبوست× | پرسشنامه کوتاه بیماری التهابی روده× | |
|---|---|---|
| حوزه | گوارش | گوارش |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 2005 | 2004 |
| پدیدآور≠ | Marquis, P., De La Loge, C., Dubois, D., et al. | Guyonnet, D., Chassany, O., Ducroc, R., et al. |
| نوع | Self-report | Self-report |
| منبع بنیادین≠ | Marquis, P., De La Loge, C., Dubois, D., McDermott, A., & Chassany, O. (2005). Development and validation of the Patient Assessment of Constipation-Quality of Life questionnaire. Scandinavian Journal of Gastroenterology, 40(5), 540–551. DOI ↗ | Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465. link ↗ |
| نامهای دیگر | PAC-QoL, PAC-Q | IBDQ-32, Short IBDQ |
| مرتبط | 4 | 4 |
| خلاصه≠ | The Patient Assessment of Constipation Quality of Life (PAC-QoL) is a validated, patient-reported outcome measure designed to assess the impact of functional constipation on physical, psychological, and social well-being. Developed by Marquis and colleagues in 2005, the PAC-QoL comprises 28 items organized into four domains: Physical Discomfort, Psychosocial Discomfort, Worries and Concerns, and Satisfaction. The PAC-QoL is responsive to treatment and widely used in constipation clinical trials and practice. | The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice. |
| ScholarGateمجموعهداده ↗ |
|
|